Cargando…
Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development
Schistosomiasis is a neglected tropical disease inflicting significant morbidity in humans worldwide. The disease is caused by infections with a parasitic trematode belonging to the genus Schistosoma. Over 250 million people are currently infected globally, with an estimated disability-adjusted life...
Autor principal: | Molehin, Adebayo J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646453/ https://www.ncbi.nlm.nih.gov/pubmed/33173371 http://dx.doi.org/10.2147/RRTM.S274518 |
Ejemplares similares
-
Schistosomiasis vaccine development: update on human clinical trials
por: Molehin, Adebayo J.
Publicado: (2020) -
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects
por: Molehin, Adebayo J., et al.
Publicado: (2022) -
Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons
por: Rojo, Juan U., et al.
Publicado: (2017) -
Process Development of Sj-p80: A Low-Cost Transmission-Blocking Veterinary Vaccine for Asiatic Schistosomiasis
por: Molehin, Adebayo J., et al.
Publicado: (2021) -
Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment
por: Melkus, Michael W., et al.
Publicado: (2020)